ROKIT HEALTHCARE Inc. Logo

ROKIT HEALTHCARE Inc.

Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.

376900 | KO

Overview

Corporate Details

ISIN(s):
KR7376900007
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로10길 9, 12층, 서울특별시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ROKIT HEALTHCARE Inc. is a biotechnology company specializing in hyper-personalized organ regeneration and regenerative medicine. Established in 2012, the company develops and commercializes advanced healthcare solutions centered on its proprietary 3D and 4D bioprinting technologies, specialized bioinks, and AI-driven platforms. Its primary focus is on providing effective treatments for chronic conditions, such as diabetic foot ulcers and skin ailments, by shifting the treatment paradigm from conventional surgery to autologous organ regeneration. The company has secured patents for its innovative multi-organ bioprinting technology, aiming to offer safer and more effective therapeutic options worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 48.9 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정 (임시주주총회)
Korean 4.3 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-18 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-07-16 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 72.0 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 118.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB

Automate Your Workflow. Get a real-time feed of all ROKIT HEALTHCARE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROKIT HEALTHCARE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROKIT HEALTHCARE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
Metagenomi, Inc. Logo
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America
MGX
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Mips Logo
Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.
Sweden
MIPS
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC
Monopar Therapeutics Logo
Clinical-stage biotech developing radiopharmaceuticals for oncology and therapies for rare diseases.
United States of America
MNPR
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland
MURA
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P

Talk to a Data Expert

Have a question? We'll get back to you promptly.